Relationship between metabolic syndrome and clinical features, and its personal-social performance in patients with schizophrenia

dc.authorid0000-0002-5825-9029
dc.authorid0009-0009-2688-7328
dc.contributor.authorSaatçioğlu, İbrahim Ömeren_US
dc.contributor.authorKalkan, Muraten_US
dc.contributor.authorFıstıkçı, Nurhanen_US
dc.contributor.authorErek, Şakireen_US
dc.contributor.authorKılıç, Kasım Candanen_US
dc.date.accessioned2016-02-17T08:05:21Z
dc.date.available2016-02-17T08:05:21Z
dc.date.issued2016-06
dc.departmentIşık Üniversitesi, Fen Edebiyat Fakültesi, Psikoloji Bölümüen_US
dc.departmentIşık University, Faculty of Arts and Sciences, Department of Psychologyen_US
dc.description.abstractThe aim of this study was to evaluate the metabolic syndrome (MS) criteria and also to investigate the effects of MS on medical treatment, clinical course and personal and social performance in patients with schizophrenia. One hundred-sixteen patients with schizophrenia were included in the study. Measurements of MS were calculated in all patients. Brief Psychiatric Rating Scale, Scale for the Assessment of Positive Symptoms, Scale for the Assessment of Negative Symptoms, Calgary Depression Scale for Schizophrenia, Personal and Social Performance Scale (PSP) were applied. The frequency of MS according to IDF criteria was 42.2 % among the patients. There was no significant difference between patients with and without MS in terms of age. The ratios of MS were 62.5 % for the group taking typical and atypical antipsychotics together and 35.7 % for the group taking two or more atypical antipsychotics together. The duration of disorder in patients with MS was higher than those without MS. Furthermore there was no significant difference between the schizophrenic patients with and without MS, in terms of PSP scores. Our findings showed that the duration of illness, high scores of BMI, use of clozapine or concurrent use of typical and atypical antipsychotics, depressive and negative symptoms of schizophrenia were significant risk factors for the development of MS.en_US
dc.description.versionPublisher's Versionen_US
dc.identifier.citationSaatcioglu, O., Saatcioglu, O., Kalkan, M., Kalkan, M., Fistikci, N., Fistikci, N., . . . Kilic, K. C. (2016). Relationship between metabolic syndrome and clinical features, and its personal-social performance in patients with schizophrenia. Psychiatric Quarterly, 87(2), 265-280. doi:10.1007/s11126-015-9384-0en_US
dc.identifier.doi10.1007/s11126-015-9384-0
dc.identifier.endpage280
dc.identifier.issn1573-6709
dc.identifier.issn0033-2720
dc.identifier.issue2
dc.identifier.pmid26174109
dc.identifier.scopus2-s2.0-84964240665
dc.identifier.scopusqualityQ1
dc.identifier.startpage265
dc.identifier.urihttps://hdl.handle.net/11729/749
dc.identifier.urihttp://dx.doi.org/10.1007/s11126-015-9384-0
dc.identifier.volume87
dc.identifier.wosWOS:000374688400006
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakSocial Sciences Citation Index (SSCI)en_US
dc.institutionauthorSaatçioğlu, İbrahim Ömeren_US
dc.institutionauthorid0000-0002-5825-9029
dc.language.isoenen_US
dc.peerreviewedYesen_US
dc.publicationstatusPublisheden_US
dc.publisherSpringeren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.sourcePsychiatric Quarterlyen_US
dc.subjectSchizophreniaen_US
dc.subjectMetabolic syndromeen_US
dc.subjectAntipsychoticsen_US
dc.subjectFunctionalityen_US
dc.titleRelationship between metabolic syndrome and clinical features, and its personal-social performance in patients with schizophreniaen_US
dc.typeArticleen_US
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
749.pdf
Boyut:
411.02 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Publisher's Version
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: